India reviews AstraZeneca side effects after concerns in Europe

Author: 
AFP
article author: 
ID: 
1615620660135341500
Sat, 2021-03-13 06:46

NEW DELHI: India will carry out a deeper review of post-vaccination side effects from the AstraZeneca shot next week although no cases of blood clots have been reported so far, an official told AFP Saturday.
New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca’s COVID-19 jab.
Denmark, Norway and Iceland paused use of the drugmaker’s shot as a precaution after isolated reports of recipients developing blood clots.

Main category: 

Leave a Reply

Your email address will not be published. Required fields are marked *